Question to the Department of Health and Social Care:
To ask Her Majesty's Government what assessment they have made of trials taking place in Sao Paulo of Azithromycin and Hydroxychloroquine for the treatment of COVID-19.
The Department is considering carefully all available evidence around the potential of different drugs for use in treating COVID-19, including from clinical trials in the United Kingdom and overseas.
Hydroxychloroquine and azithromycin are not currently licensed to treat COVID-19-related symptoms or prevent infection. Hydroxychloroquine and azithromycin are both being tested through clinical trials in the UK. These clinical trials are ongoing, so no conclusions have yet been reached on the safety and effectiveness of these medicines to treat COVID-19.